243 related articles for article (PubMed ID: 36576329)
1. Iron metabolism abnormalities in autoimmune hemolytic anemia and
Zhao M; Wang Y; Yang J; Wang Y; Feng Y; Chen L; Shao Z; Wang H; Xing L
Ann Med; 2023 Dec; 55(1):231-240. PubMed ID: 36576329
[TBL] [Abstract][Full Text] [Related]
2. miR-150 regulates B lymphocyte in autoimmune hemolytic anemia/Evans syndrome by c-Myb.
Xing L; Xu W; Qu Y; Zhao M; Zhu H; Liu H; Wang H; Su X; Shao Z
Int J Hematol; 2018 Jun; 107(6):666-672. PubMed ID: 29488168
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of CD(4)(+)CD(69)(+) T lymphocytes in patients with autoimmune hemolytic anemia/Evans syndrome].
Xing LM; Xu WY; Duan NN; Qu YY; Liu ZY; Shao ZH
Zhonghua Nei Ke Za Zhi; 2018 Sep; 57(9):656-660. PubMed ID: 30180450
[No Abstract] [Full Text] [Related]
4. Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions.
Chen C; Wang L; Han B; Qin L; Ying B
Medicine (Baltimore); 2020 Jan; 99(2):e18739. PubMed ID: 31914091
[TBL] [Abstract][Full Text] [Related]
5. A New Murine Model of Primary Autoimmune Hemolytic Anemia (AIHA).
Dei Zotti F; Qiu A; La Carpia F; Moriconi C; Hudson KE
Front Immunol; 2021; 12():752330. PubMed ID: 34867985
[TBL] [Abstract][Full Text] [Related]
6. Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria).
Lefebvre T; Millot S; Richard E; Blouin JM; Lalanne M; Lamrissi-Garcia I; Costet P; Lyoumi S; Gouya L; Puy H; Moreau-Gaudry F; de Verneuil H; Karim Z; Ged C
Biochem Biophys Res Commun; 2019 Dec; 520(2):297-303. PubMed ID: 31601421
[TBL] [Abstract][Full Text] [Related]
7. EPO-dependent induction of erythroferrone drives hepcidin suppression and systematic iron absorption under phenylhydrazine-induced hemolytic anemia.
Jiang X; Gao M; Chen Y; Liu J; Qi S; Ma J; Zhang Z; Xu Y
Blood Cells Mol Dis; 2016 May; 58():45-51. PubMed ID: 27067488
[TBL] [Abstract][Full Text] [Related]
8. Red Blood Cell Transfusion in Patients With Autoantibodies: Is It Effective and Safe Without Increasing Hemolysis Risk?
Park SH; Choe WH; Kwon SW
Ann Lab Med; 2015 Jul; 35(4):436-44. PubMed ID: 26131416
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model.
Millot S; Delaby C; Moulouel B; Lefebvre T; Pilard N; Ducrot N; Ged C; Lettéron P; de Franceschi L; Deybach JC; Beaumont C; Gouya L; De Verneuil H; Lyoumi S; Puy H; Karim Z
Haematologica; 2017 Feb; 102(2):260-270. PubMed ID: 28143953
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis.
Vokurka M; Krijt J; Sulc K; Necas E
Physiol Res; 2006; 55(6):667-674. PubMed ID: 16497104
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in iron status and hepcidin expression in rats.
Kong WN; Niu QM; Ge L; Zhang N; Yan SF; Chen WB; Chang YZ; Zhao SE
Biol Trace Elem Res; 2014 Aug; 160(2):258-67. PubMed ID: 24962641
[TBL] [Abstract][Full Text] [Related]
12. Effects of IL-10 on iron metabolism in LPS-induced inflammatory mice via modulating hepcidin expression.
Huang P; Wang J; Lin X; Yang FF; Tan JH
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3469-3475. PubMed ID: 28829493
[TBL] [Abstract][Full Text] [Related]
13. [Siwu decoction improves iron deficiency anemia in infant rats and regulates iron metabolism].
He R; Wang HJ; Zhou Y; Li JJ; Xu XY
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):944-950. PubMed ID: 28994539
[TBL] [Abstract][Full Text] [Related]
14. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
[TBL] [Abstract][Full Text] [Related]
15. C1-inhibitor treatment in patients with severe complement-mediated autoimmune hemolytic anemia.
de Boer ECW; Jalink M; Delvasto-Nuñez L; Meulenbroek EM; Baas I; Janssen SR; Folman CC; Gelderman KA; Wouters D; Engel MD; de Haas M; Kersten MJ; Jongerius I; Zeerleder S; Vos JMI
Blood Adv; 2023 Jul; 7(13):3128-3139. PubMed ID: 36920779
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of hemolytic characteristics among paroxysmal nocturnal hemoglobinuria, autoimmune hemolytic anemia and hereditary spherocytosis].
Li WW; Shi J; Huang ZD; Nie N; Shao YQ; Li XX; Ge ML; Zhang J; Huang JB; Jin P; Wang M; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):299-304. PubMed ID: 29779325
[No Abstract] [Full Text] [Related]
17. [Clinical and Laboratory Characteristics of Primary Autoimmune Hemolytic Anemia Patients with Negative Results of DAT by Tube Test But Positive Results by Microcolumn Gel Assay].
Wang Z; Zhou XL; Bo LJ; Xu Y; Liu HJ; Zhao YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1532-1535. PubMed ID: 36208261
[TBL] [Abstract][Full Text] [Related]
18. Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.
Callan MB; Thawley VJ; Marryott KA; Shabro A; Fernando S; Kahn S; Hudson KE; Hod EA
Transfusion; 2021 Dec; 61(12):3309-3319. PubMed ID: 34633666
[TBL] [Abstract][Full Text] [Related]
19. A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.
Sun CC; Vaja V; Chen S; Theurl I; Stepanek A; Brown DE; Cappellini MD; Weiss G; Hong CC; Lin HY; Babitt JL
Nephrol Dial Transplant; 2013 Jul; 28(7):1733-43. PubMed ID: 23345622
[TBL] [Abstract][Full Text] [Related]
20. Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases.
Kamesaki T; Toyotsuji T; Kajii E
Am J Hematol; 2013 Feb; 88(2):93-6. PubMed ID: 23169533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]